losclouds

Karyopharm TherapeuticsKaryopharm Therapeutics

Pharmaceutical company developing and commercializing cancer treatments targeting nuclear export pathways, including XPOVIO (selinexor) for multiple myeloma, diffuse large B-cell lymphoma, and other hematologic malignancies.

About

What Karyopharm Therapeutics is

Pharmaceutical company developing and commercializing cancer treatments targeting nuclear export pathways, including XPOVIO (selinexor) for multiple myeloma, diffuse large B-cell lymphoma, and other hematologic malignancies.

losclouds keeps public details for this profile. There are no catalog offerings to compare yet.

EnterpriseHealthcare

At a glance

Karyopharm Therapeutics service facts
FactValue
Official sitehttps://karyopharmtherapeutics.com
Status coveragePublic status page
Founded2008
HeadquartersNewton, Massachusetts, United States
CategoriesEnterprise, Healthcare
Loading offerings...